ReviewFrontiers in immunology2026
Neutrophil extracellular traps: the hidden driver of gastrointestinal cancer and emerging therapeutic strategies.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As the most abundant subset of leukocytes in the innate immune system, neutrophils are central to host defense, particularly against bacterial and fungal infections. With advances in tumor microenvironment (TME) research, their multifunctional roles in tumor biology have been clarified, and the identification of neutrophil extracellular traps (NETs) has provided a novel perspective for understanding neutrophil-mediated regulation of tumor initiation, progression, and metastasis. NETs are reticular structures of chromatin fibers released by activated neutrophils, comprising DNA backbones, histones, and various antimicrobial proteins, initially recognized as an antibacterial defense mechanism. However, recent studies reveal NETs exert a dual role in tumor progression: directly promoting metastasis by enhancing tumor cell migration, trapping circulating tumor cells (CTCs), reactivating dormant cancer cells, and increasing vascular permeability, while also reshaping the TME to support pre-metastatic niche formation. This review systematically summarizes the molecular mechanisms of NETs in gastrointestinal tumor initiation, progression, and metastasis, and explores potential NETs-targeted anti-tumor therapeutic strategies, aiming to provide a theoretical basis for novel gastrointestinal tumor treatment directions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.